Patent 7705022 was granted and assigned to Lankenau Institute for Medical Research on April, 2010 by the United States Patent and Trademark Office.
Novel indoleamine 2,3-dioxygenase (IDO) inhibitors, compositions comprising the same, and methods of use thereof are disclosed.